DBC1 Antikörper (AA 101-200) (Cy5)
-
- Target Alle DBC1 (BRINP1) Antikörper anzeigen
- DBC1 (BRINP1) (Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1))
-
Bindungsspezifität
- AA 101-200
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DBC1 Antikörper ist konjugiert mit Cy5
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human, Maus, Ratte
- Homologie
- Cow,Pig,Horse,Chicken,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- synthetic peptide from human DBC1 conjugated to KLH
- Isotyp
- IgG
- Top Product
- Discover our top product BRINP1 Primärantikörper
-
anti-Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1) antibody
BRINP1 Reaktivität: Human, Maus WB, IP, ICC Wirt: Maus Monoclonal unconjugated
anti-Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1) (AA 20-320) antibodyBRINP1 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1) (AA 101-200) antibodyBRINP1 Reaktivität: Human, Maus, Ratte WB, ELISA, IF (cc), IF (p), IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1) (AA 1-320) antibodyBRINP1 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1) (AA 1-320) antibodyBRINP1 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1) (AA 85-111), (N-Term) antibodyBRINP1 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB22619 unconjugated
anti-Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1) (AA 662-761) antibodyBRINP1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- DBC1 (BRINP1) (Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1))
- Andere Bezeichnung
- DBC1/deleted in bladder cancer 1 (BRINP1 Produkte)
- Synonyme
- Dbc1 antikoerper, Dbccr1 antikoerper, BRINP antikoerper, Fam5a antikoerper, BMP/retinoic acid inducible neural specific 1 antikoerper, bone morphogenic protein/retinoic acid inducible neural specific 1 antikoerper, Brinp1 antikoerper, BRINP1 antikoerper
- Hintergrund
-
Synonyms: DBC1, FAM5A, DBCCR1, BMP/retinoic acid-inducible neural-specific protein 1, Deleted in bladder cancer protein 1, BRINP1, IB3089A
Background: Inhibits cell proliferation by negative regulation of the G1/S transition. Mediates cell death which is not of the classical apoptotic type and regulates expression of components of the plasminogen pathway.
- Gen-ID
- 1620
- UniProt
- O60477
-
